<SEC-DOCUMENT>0001628280-24-032856.txt : 20240724
<SEC-HEADER>0001628280-24-032856.hdr.sgml : 20240724
<ACCEPTANCE-DATETIME>20240724170657
ACCESSION NUMBER:		0001628280-24-032856
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240724
FILED AS OF DATE:		20240724
DATE AS OF CHANGE:		20240724

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORGANIGRAM HOLDINGS INC.
		CENTRAL INDEX KEY:			0001620737
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38885
		FILM NUMBER:		241138923

	BUSINESS ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3
		BUSINESS PHONE:		506-384-1571

	MAIL ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORGANIGRAM HOLDINGS INC
		DATE OF NAME CHANGE:	20140926
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-kxjuly242024xfinal.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="iacbfa8571c9545fc8f095f89d63b4de0_1"></div><div style="min-height:54pt;width:100%"><div style="padding-right:-4.5pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Washington, D.C. 20549</font></div><div style="padding-left:216pt;padding-right:216pt;text-align:center"><font><br></font></div><div style="margin-top:7pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%">FORM 6-K</font></div><div style="padding-left:216pt;padding-right:216pt;text-align:center"><font><br></font></div><div style="margin-top:7pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">For the month July 2024</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Commission File Number&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%;text-decoration:underline">001-38885</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%;text-decoration:underline">ORGANIGRAM HOLDINGS INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(Translation of registrant&#8217;s name into English)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:160%">145 King Street West, Suite 1400</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:160%;text-decoration:underline">Toronto, Ontario, Canada M5H 1J8 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(Address of principal executive offices)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Form 20-F&#160;&#91;  &#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Form 40-F&#160;&#91; X &#93;</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T                       Rule 101(b)(1)&#58;&#160;&#160;&#91;  &#93;</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T                       Rule 101(b)(7)&#58;  &#91;  &#93;</font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-4.5pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="padding-right:-4.5pt"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%">SUBMITTED HEREWITH</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%;text-decoration:underline">Exhibits</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:3.75pt"><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="july-phylosthirdtranchefun.htm" style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">99.1</a></font></div><div style="margin-bottom:1.5pt;margin-top:3.75pt"><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"><br></font></div></td><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:3.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">News release dated July 24, 2024</font></div><div style="margin-bottom:1.5pt;margin-top:3.75pt"><font><br></font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.998%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-4.5pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="padding-right:-4.5pt"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%">SIGNATURE</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:139%">ORGANIGRAM HOLDINGS INC.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">&#47;s&#47; Beena Goldenberg        </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">              </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Beena Goldenberg</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Chief Executive Officer</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Date&#58; July 24, 2024</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-4.5pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>july-phylosthirdtranchefun.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="iac83cb6315b3460f8b3f456a42d1b1d1_1"></div><div style="min-height:86.4pt;width:100%"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Aptos',san-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#2f5496;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:120%">Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:200px;margin-bottom:5pt;vertical-align:text-bottom;width:199px"></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The partial third tranche investment is expected to enable Organigram to expand its product portfolio, addressing consumer demand for unique and differentiated aromas and flavours.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">This strategic funding supports the growth and diversification of Organigram&#8217;s offerings with a view to enhancing its market position and appeal to consumers.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Already a cultivation leader in high THCV cultivars, Organigram will now pilot higher potency rare cannabinoids such as CBG, CBC and CBDV.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TORONTO, July 24, 2024 --- Organigram Holdings Inc. (NASDAQ&#58; OGI) (TSX&#58; OGI), (the &#34;Company&#34; or &#34;Organigram&#34;), a leading licensed producer of cannabis, announced today that it has completed an early partial funding of its final third tranche investment into Phylos Bioscience Inc. (&#8220;Phylos&#8221;), a U.S. cannabis genetics company and provider of production ready seeds, with the remaining portion of the final tranche to be funded upon completion of the newly expanded final milestone. </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the expanded milestone, Phylos is required to deliver 21 unique auto-flower seed varietals for testing and phenotyping by Organigram no later than September 30, 2024, followed by a second cohort of 21 auto flower seed varietals to be delivered no later than January 31, 2025. In addition to the auto-flower seeds, Organigram received an expanded genetics licence from Phylos that, in addition to THCV, includes access to high potency CBG, CBC and CBDV seed based cultivars. </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;We are pleased with the progress we&#8217;ve achieved to date and the benefits that have stemmed from this strategic investment. The continuous development and milestone achievements are instrumental in expanding and differentiating Organigram&#8217;s portfolio of seed-based cultivars, which are currently being scaled and have started to deliver tangible benefits to the organization,&#8221; says Borna Zlamalik, Senior Vice President, R&#38;D and Innovation at Organigram. </font></div><div style="margin-top:2pt"><font style="color:#2f5496;font-family:'Arial',sans-serif;font-size:13pt;font-weight:400;line-height:120%">Organigram&#8217;s THCV Portfolio </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Organigram has exclusive rights in Canada (until May 2028) to commercialize THCV derived from Phylos&#8217; cultivars, including Get S**T Done (1&#58;3 THC&#58; THCV) and Joyride (1&#58;1 THC&#58;THCV), two popular cultivars with THCV concentrations of 16+% that are  higher than those available elsewhere in the market. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Organigram was one of the first cannabis producers to launch THCV products in Canada with SHRED&#8217;ems late last year. Since then, Organigram has launched six THCV SKUs in-market, across four formats, in a variety of ratios for consumers to experience and enjoy. Organigram is currently </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the only cannabis producer in Canada to offer whole-flower derived THCV products in the pre-milled and pre-roll categories.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Aptos',san-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Organigram&#8217;s THCV portfolio includes&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SHRED Supersonic Citrus THCV pre-milled Flower&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SHRED X Guava Lime Go-Time Heavies Infused Pre- rolls&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SHRED&#8217;ems Guava Lime Go-Time 1&#58;1 THCV&#58;THC Gummies&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SHRED&#8217;ems Pink Lemonade Yuzu 2&#58;1 THCV&#58;THC Gummies&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Trailblazer Hustle n&#8217; Haze THCV pre-rolls&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Monjour Cherry Citrus Sunshine 8&#58;3&#58;1 CBD&#47;THCV&#47;THC Gummies&#160;</font></div><div style="margin-top:2pt"><font style="color:#2f5496;font-family:'Arial',sans-serif;font-size:13pt;font-weight:400;line-height:120%">Convertible Loan Details </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Including the current partial third tranche advance, Organigram has now advanced an aggregate of US $7 million to Phylos in the form of a convertible loan (the &#8220;Convertible Loan&#8221;) funded in tranches. The balance of the third tranche, being an additional US $1 million, will be advanced to Phylos conditional upon successful completion of the expanded milestone no later than March 31, 2026. </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Loan accrues paid-in-kind interest (&#8220;PIK&#8221;) at a rate of U.S. Prime + 3.5% (with an overall cap of 11%) subject to certain conditions.  The maturity date of the Convertible Loan is May 25, 2028, subject to one-year extensions and certain conditions. The Convertible Loan&#8217;s principal and PIK interest outstanding are convertible into common share equity of Phylos under certain circumstances (including but not limited to federal legalization or decriminalization of cannabis in the United States).</font></div><div style="margin-top:2pt"><font style="color:#2f5496;font-family:'Arial',sans-serif;font-size:13pt;font-weight:400;line-height:120%">About Organigram</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Organigram is a NASDAQ Global Select Market and TSX listed company whose primary wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis, cannabis-derived products and cannabis-infused edibles in Canada.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Organigram is focused on producing high-quality, cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company&#8217;s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O&#8217; Buds, SHRED, SHRED&#8217;ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates cultivation and manufacturing facilities in Moncton, New Brunswick and Lac-Sup&#233;rieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by Health Canada under the Cannabis Act and the Cannabis Regulations (Canada).</font></div><div style="margin-top:2pt"><font style="color:#2f5496;font-family:'Arial',sans-serif;font-size:13pt;font-weight:400;line-height:120%">About Phylos Bioscience Inc.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phylos is a cannabis genetics company focused on producing genetics for the highest quality varietals that can be grown at scale in a cost-effective way. Phylos owns and sells products that are legal under US and Canadian laws &#8211; seeds that the US Drug Enforcement Administration (&#8220;DEA&#8221;) has deemed are hemp and exempt from the CSA under US law &#8211; and intellectual property related to the seeds. Phylos supports commercial-scale cultivation with the industry&#8217;s first Production-Ready Seed&#8482;&#58; premium, phenotypically stable, fully feminized F1 hybrid seeds that deliver exceptional flower quality, potency, vigor, and yield. Phylos also leverages its proprietary technologies and its cultivation, extraction, and formulation expertise to provide partners with unparalleled Rare Cannabinoid genetics for natural, safe and effective ingredients.</font></div><div style="margin-top:2pt"><font style="color:#2f5496;font-family:'Arial',sans-serif;font-size:13pt;font-weight:400;line-height:120%">Forward-Looking Information</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as &#8220;plans&#8221;, &#8220;expects&#8221;, &#8220;estimates&#8221;, &#8220;intends&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221; or variations of such words and phrases or state that certain actions, events, or results &#8220;may&#8221;, &#8220;could&#8221;, &#8220;would&#8221;, &#8220;might&#8221; or &#8220;will&#8221; be taken, occur or be achieved. Forward-looking </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Aptos',san-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks such as completion of the milestones by target dates established, regulatory and market conditions, the success of seed based production and the outcome of any commercialization efforts together with those factors and risks disclosed in the Company&#8217;s most recent annual information form, management&#8217;s discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.</font></div><div><font style="color:#2f5496;font-family:'Arial',sans-serif;font-size:13pt;font-weight:400;line-height:120%">For Media enquiries&#58; </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Megan McCrae</font><font style="color:#2f5496;font-family:'Arial',sans-serif;font-size:13pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President of Global Brands and Corporate Affairs&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">megan.mccrae&#64;organigram.ca</font><font style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div><font style="color:#2f5496;font-family:'Arial',sans-serif;font-size:13pt;font-weight:400;line-height:120%">For Investor Relations enquiries&#58; </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Max Schwartz </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director of Investor Relations</font></div><div><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">investors&#64;organigram.ca</font><font style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P@ 1" '@ =\# 2(  A$! Q$!_\0
M&P   @,! 0$              @,  00%!@?_Q  9 0$! 0$! 0
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M(\XGY)0B2H1.,(KDCP>!#:&\D'@YGLE[7A-Y(^I>#$6=-#IG%GE'DY-&7LO
MY_88D1I3.+BUM@7MLCX<EY<\&<&61\RRF2RI<N!U,MQ&V-+'V[+R<$SCQ<LH
M<OL]'3DH1Y,^[BO+\MN,SILXX%%DJ;9QE$7(;.3,DGG:#''DNFT8>SC$PC@<
M3 H9."%02/1'\6L$5RJ5H_8O*\F")C(O!+>+\MD9LSY7Y98S XB]^SFT<E)/
M\88$HY366L%7,8T^G&#JTDW<4QUZ8Z\$NM$=="K1@G6Y'79U#JG.!]K4? IG
M+)XV8XB@N,X.(EDA'QMAMDO)&."K+PXX3DV9R_\ Q%F1Q3&>R'@EY/1[$L#\
M"\OR1PQX&]UYAYZC1')"I)DGS27%=6(JL&=& Z!T_'")P'E"CXXX./V\<N?O
M)' H'$EE'(4C_'MJ&'@?@=6!U92:,>9O"RY2_P#+1$B8PN1[7$X'%F&-D?+;
M43S-QAQ31P)+SQ. O>,P4WEJ2)-H]Q;F>3[F)<4D9E$5:2.N4ZD&2@FGS3YH
M<\[-&-HR8IC624#CY2R*$42J*)*OD;>U+\B4E"*ER:]D_2*;^YO$GE"DSJHZ
MAU#J/'L_%*+;4H(]BDAQ&EE/+G$4?%.9Q:E^+DDQ5.(I^.J<L"J(Y0%Q9-03
MY4A=(C# AQ3.F8VE$<&MLBJ&<BIDIQ@I5VS.1H<G@H>LX*M7F4_?_IX/:?OT
MY^3UM__$ "41  (! P,$ P$!           !$1 2, ,4( ) 05$A,5!@@/_:
M  @! P$!/P&242B42B47(T=?HZ>F&;G3]FYT_9N=/V;G2]FZTO9NM+V;G2]E
MR+D7(N1<BY%R.MRBUEK+66LM9:RU_P" (&OXU$#58I%8%6"$AD(:$AH2$AJL
M\.D8V>.'CAYJA_9X/ R/@=>KFF-X)I-)I<-DDC9)))/?SD0\,8HP^14=(HZ1
M1D$$9TJP-48QC%1C6%$<YHJ-T;[F:-\IRK\Q=F\DDDXXHL")XNJ_"@CC!)."
M*R3CGC(\,Y9)X23BFGUP@^,4YI'GBC(HJ__$ "81  (! P,#!0$!
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ML5!S6-/6";I].I3#:C18HCEC196=E:0-KDI?TEG5\PF]&H>&W4KJPX-\RJ=
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M 0 " @(" 00" P$! 0    $ $2$Q$$%187$@@9&AL?#!T>'Q,$#_V@ ( 0$
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M+B)PNXI@B\5!]V= [@6L]YT^2K)X8]W?>I_ZQ ?]QR'9BX>FU@/O'V01FHP
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M ^(6H#JK'S#$8,38S(GP]_'R0@7C2540IP&AYA7&%4,5+NE-RZ-,Z4!"\+$
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MD24BI!/-\]TROBA; W_X +U"AJU$^68,&D\:/HUSWJQK>/M8TR'/'/;^ /\
MO+C\CN!1.,O',#^GD$\& 'Z_1$ILW''%:/\ 4P@@_\0 (1$  P " @(# 0$
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M(3%!46$0<8&1H=&QP?#QX3 @_]H " $!  $_$/\ [?GO_OS/QO\ [_[W9_\
M?_O_ -07_/\ B?Z/ZG^C^I_T?ZG_ &/ZG^C^I_@_J?Z/ZA_@_P!2W_'^)_T/
MZG_2_J?]/^H +Y5*/ZG_ $/ZEG[/ZG_6_J?][^HG^[^I7$/G^H"8?G^H)?\
MI\3_ %/U$/\ 3^(E_C_$_P ']1,_Q_$_WW^)SK\OU$X"T=_U/^[_ %,O]O\
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MC*!5NFSKN9,(P8>K)0C:P.OA+S FH^D+6$>$I4MTNM"!]B9EU>7%RM2&L&"
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M/QR*H(/M@N84>!0K->TJ8T555OM+WP&<8F"R68.V6HA3-J^)@Q HM*0!D/:
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:0%@V8?,"7 ZE?;5XG  1CEX8JCQ#E7B?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
